母乳喂养与BRCA1/2突变女性上皮性卵巢癌风险
这项匹配病例对照分析纳入1650例病例和2702例对照,评估BRCA1/2突变女性中母乳喂养与上皮性卵巢癌风险的关联。曾母乳喂养与风险降低23%相关(OR=0.77),母乳喂养≥7个月与风险降低32%相关(OR=0.68),且与口服避孕药联合保护作用更强。
要点
- BRCA1/2突变女性中,曾母乳喂养与卵巢癌风险降低23%相关
- 母乳喂养≥7个月与风险降低32%相关,保护效应不随BRCA基因或诊断年龄变化
- 母乳喂养联合口服避孕药具有更强保护作用(OR=0.47)
核心结论
- BRCA1或BRCA2突变女性中,母乳喂养至少7个月对上皮性卵巢癌具有保护作用,且独立于口服避孕药使用。
研究设计与样本
- 匹配病例对照分析,按出生年份、居住国家、BRCA基因和个人乳腺癌史匹配,纳入1650例病例和2702例对照。
主要发现
- 曾母乳喂养与卵巢癌风险降低23%相关(OR=0.77;95%CI 0.66-0.90;P=0.001)。
- 母乳喂养从1个月到7个月保护效应增加,之后相对稳定。
- 与从未母乳喂养相比,母乳喂养≥7个月与风险降低32%相关(OR=0.68;95%CI 0.57-0.81;P<0.0001),且不随BRCA基因或诊断年龄变化。
- 母乳喂养联合口服避孕药具有强保护作用(OR=0.47;95%CI 0.37-0.58;P<0.0001)。
临床怎么用
- 对BRCA1/2突变女性进行遗传咨询时,可告知母乳喂养至少7个月与卵巢癌风险降低相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: BRCA mutation carriers face a high lifetime risk of developing ovarian cancer. The strong inverse association between breastfeeding and the risk of ovarian cancer is established in the general population but is less well studied among women with a germline BRCA1 or BRCA2 mutation. METHOD: Thus, we conducted a matched case-control analysis to evaluate the association between breastfeeding history and the risk of developing ovarian cancer. After matching for year of birth, country of residence, BRCA gene and personal history of breast cancer, a total of 1650 cases and 2702 controls were included in the analysis. Conditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CI) associated with various breastfeeding exposures. RESULTS: A history of ever-breastfeeding was associated with a 23% reduction in risk (OR = 0.77; 95%CI 0.66-0.90; P = 0.001). The protective effect increased with breastfeeding from one month to seven months after which the association was relatively stable. Compared to women who never breastfed, breastfeeding for seven or more months was associated with a 32% reduction in risk (OR = 0.68; 95%CI 0.57-0.81; P < 0.0001) and did not vary by BRCA gene or age at diagnosis. The combination of breastfeeding and oral contraceptive use was strongly protective (0.47; 95%CI 0.37-0.58; P < 0.0001). CONCLUSIONS: These findings support a protective effect of breastfeeding for at least seven months among women with a BRCA1 or BRCA2 mutation, that is independent of oral contraceptive use.
引用
- Kotsopoulos J, Gronwald J, McCuaig JM, et al. Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol. 2020. PMID: 33010967. doi:10.1016/j.ygyno.2020.09.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。